Xin Chanye recently announced that the company obtained EU IVDD CE certification for Nipah virus test kits in 2022. According to Jinshi Data, the company currently meets the requirements to enter the European medical market, which also marks another step forward in Xin Chanye's international layout in the key infectious disease testing field. As an emerging infectious disease, Nipah virus detection is a critical testing need, and the approval of related test kits provides significant support for the company's expansion into overseas markets.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Xin Chanye recently announced that the company obtained EU IVDD CE certification for Nipah virus test kits in 2022. According to Jinshi Data, the company currently meets the requirements to enter the European medical market, which also marks another step forward in Xin Chanye's international layout in the key infectious disease testing field. As an emerging infectious disease, Nipah virus detection is a critical testing need, and the approval of related test kits provides significant support for the company's expansion into overseas markets.